Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2011-08-09
2011-08-09
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07994154
ABSTRACT:
Novel substituted liposaccharides useful as in the prophylactic and affirmative treatment of endotoxemia including sepsis, septicemia and various forms of septic shock and methods of using these agents are provided. Also provided are methods of preparing these agents and intermediates useful therein.
REFERENCES:
patent: 4495346 (1985-01-01), Anderson et al.
patent: 4987237 (1991-01-01), Myers et al.
patent: 5066794 (1991-11-01), Shiba
patent: 5413785 (1995-05-01), Nanji
patent: 5530113 (1996-06-01), Christ et al.
patent: 5681824 (1997-10-01), Christ et al.
patent: 5750664 (1998-05-01), Christ et al.
patent: 5935938 (1999-08-01), Christ et al.
patent: 6184366 (2001-02-01), Christ et al.
patent: 6417172 (2002-07-01), Rossignol et al.
patent: 6683063 (2004-01-01), Roggignol et al.
patent: 7737129 (2010-06-01), Christ et al.
patent: 0 172 581 (1986-02-01), None
patent: 0 437 016 (1991-07-01), None
patent: 0 536 969 (1993-04-01), None
patent: 2 179 945 (1987-03-01), None
patent: 2 220 211 (1990-01-01), None
patent: 3-135990 (1991-06-01), None
patent: 4-235193 (1992-08-01), None
patent: WO 87/00174 (1987-01-01), None
patent: WO 91/01134 (1991-02-01), None
patent: WO 96/39411 (1996-12-01), None
Adachi et al., “Antibiotics Prevent Liver Injury in Rats Following Long-term Exposure to Ethanol,” Gastroenterology 108:218-224, 1995.
Bone et al., “Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis,” Chest: The Cardiopulmonary J. 101 :1644-1655, 1992.
Knaus et al., “The APACHE III Prognostic System: Risk Prediction of Hospital Mortality for Critically III Hospitalized Adults,” Chest: The Cardiopulmonary J. 100:1619-1636, 1991.
Knaus et al., “Recommendations for Use of Folic Acid to Reduce Number of Spina Bifida Cases and Other Neural Tube Defects,” JAMA 269:1233-1241, 1993.
Mukaiyama, “Highly Stereoselective Preparation of a -Glucosides Utilizing Anomerization Reaction with MgBrzOEtz and a Catalytic Amount of Titanium (IV) Tetrahalides,” The Chemical Society of Japan, Chemistry Letters 625-626, 1997.
Rose et al., “Agonistic and Antagonistic Activities of Bacterially Derived Rhodobacter sphaeroides Lipid A: Comparison with Activities of Synthetic Material of the Proposed Structure and Analogs,” Infection and Immunity 63:833-839, 1995.
Ruff et al., “Tumor Necrosis Factor,” Lymphokines: A Forum for Immunoregulatory Cell Products; Academic Press 2:235-272, 1981.
Schwartz et al., “Endotoxin Responsiveness and Grain Dust-induced Inflammation in the Lower Respiratory Tract,” Am. J. Pathol. 267:1609-1617,1994.
Shiozaki, “Synthesis of 2-deoxy-2-[(3 R)-3-hydroxytetradecanamido]-3-0-[(3 R)-3-hydroxytetradecanyl]-4-0-phosphono-D-glucopyranose,” Carbohydrate Research 222:57-68, 1991.
Shiozaki, “Syntheses of 1-0-carboxyalkyl GLA-60 analogues,” Carbohydrate Research 283:27- 51, 1996.
Takayama et al., “Diphosphoryl Lipid A from Rhodopseudomonas sphaeroides ATCC 17023 Blocks Induction of Cachectin in Macrophages by Lipopolysaccharide,” Infection and Immunity 57:1336-1338, 1989.
Vogel et al., “BCG-induced Enhancement of Endotoxin Sensitivity in C3H/HeJ Mice,” J. Immunology 124:2004-2009,1980.
Christ William J.
Kawata Tsutomu
Kobayashi Seiichi
Rossignol Daniel P.
Ersai R&D Management Co., Ltd.
McCarter & English LLP
Peselev Elli
LandOfFree
Substituted liposaccharides useful in the treatment and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted liposaccharides useful in the treatment and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted liposaccharides useful in the treatment and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2711895